MAIA Biotechnology, Inc. MAIA Biotechnology, Inc.

MAIA Biotechnology, Inc.

MAIA

Rank in Stocks #21830
MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to... MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established in 2018, the enterprise maintains its headquarters in Chicago, Illinois.
Share Price
$1.00
Last synced: 2026-11-13
Market Cap
$60.86M
Change (1 day)
-0.99%
Change (1 year)
0.00%
Country

Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this

Category

Healthcare
EPS for MAIA Biotechnology, Inc. (MAIA)
EPS as of September 2026 TTM: $-0.48
According to MAIA Biotechnology, Inc.'s latest financial reports, its current EPS (TTM) is $-0.48. At the end of 2025 the company had an EPS of $-0.70, an increase over its 2024 EPS of $-1.05.
EPS history for MAIA Biotechnology, Inc. from 2019 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.48 -31.43%
2025 $-0.70 -33.33%
2024 $-1.05 -29.53%
2023 $-1.49 -12.35%
2022 $-1.70 44.07%
2021 $-1.18 90.32%
2020 $-0.62 1.64%
2019 $-0.61 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$-0.89 85.42%
US
$15.66 -3,362.50%
US
$-7.07 1,372.92%
US
$-5.29 1,002.08%
AU
$12.73 -2,752.54%
BE

Questions about MAIA Biotechnology, Inc.'s earnings per share (EPS)

What is MAIA Biotechnology, Inc.'s earnings per share (EPS)?

MAIA Biotechnology, Inc.'s earnings per share (EPS) over the last twelve months is $-0.48, as of Sep 2026.

What was MAIA Biotechnology, Inc.'s earnings per share (EPS) in 2025?

In 2025, MAIA Biotechnology, Inc.'s earnings per share (EPS) was $-0.70, compared with $-1.05 in 2024.

How has MAIA Biotechnology, Inc.'s earnings per share (EPS) changed since 2020?

From 2020 to 2025, MAIA Biotechnology, Inc.'s earnings per share (EPS) was highest in 2020 ($-0.62) and lowest in 2022 ($-1.70).

How does MAIA Biotechnology, Inc.'s earnings per share (EPS) compare with similar companies?

MAIA Biotechnology, Inc.'s earnings per share (EPS) ($-0.48) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.